Clinical Study Results
How has this study helped patients and researchers?
This study helped researchers learn more about the safety of durvalumab combined
with other treatments and how durvalumab combined with AZD5069 works in patients
with metastatic pancreatic cancer.
Researchers look at the results of many studies to decide which treatments work best
and are safest. This summary shows only the main results from this one study. Other
studies may provide new information or different results.
Further clinical studies with combined treatments of durvalumab and AZD5069 are
not planned.
11